Trial Outcomes & Findings for A Pragmatic Trial of Brief CBT for Anxiety in VA Primary Care (NCT NCT04523779)

NCT ID: NCT04523779

Last Updated: 2026-04-20

Results Overview

The GAD-7 is a seven-item self-report instrument for screening, diagnosis, and severity assessment of anxiety disorders. It is psychometrically strong and valid for use in the primary care setting. A GAD-7 score of 10 or higher will be required for study inclusion. The GAD-7 total score for the seven items ranges from 0 to 21: 0-4 Minimal anxiety; 5-9 Mild anxiety; 10-14 Moderate anxiety; 15-21 Severe anxiety.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

225 participants

Primary outcome timeframe

Baseline, 4-, 8-, and 12-month

Results posted on

2026-04-20

Participant Flow

Veterans enrolled in Houston, New Orleans, and San Antonio VA Medical Centers were recruited if they: 1) were diagnosed with anxiety disorders and 2) had significant anxiety symptoms (GAD-7 score≥10). Exclusion criteria: 1) cognitive impairment, 2) bipolar or psychotic disorders, 3) substance use disorders, and 4) current psychotherapy for anxiety. Recruitment involved opt-out letters, phone calls, and direct provider referral. Interested Veterans underwent 2 screenings for anxiety.

Eligibility determination occurred after informed consent. Of the 347 Veterans who signed consent forms, many were deemed ineligible at baseline due to various reasons: 1) being unreachable or declining assessment, 2) not meeting the required GAD-7 scores, 3) having an excluded mental health diagnosis, 4) receiving mental health treatment, or 5) relocating outside the catchment area. Ultimately, 225 eligible participants were randomized to treatment (60%) or Enhanced Usual Care (EUC) (40%).

Participant milestones

Participant milestones
Measure
Brief Cognitive Behavioral Therapy for Anxiety (bCBT-A)
Participants in the bCBT-A arm were offered 4-9 sessions of measurement-based care, depending on their treatment response by the fourth session. Veterans could receive bCBT-A in person or via VA Video Connect to Home. All participants took part in an initial session where they received psychoeducation on anxiety and the bCBT treatment approach, set goals, and began self-monitoring. Three core skill sessions focused on relaxation, cognitive skills, and exposure techniques followed. All participants received a final wrap-up session to review gains and plan for skill maintenance.
Enhanced Usual Care (EUC)
Participants in the EUC group received educational materials on managing anxiety, made available both by mail and through a weblink. They also received a letter encouraging them to discuss treatment options with their VA care providers. Additionally, a note was placed in the participant's electronic medical record to inform their primary care provider (PCP) and most recent Primary Care Mental Health Integration (PCMHI) provider of the presence of anxiety symptoms. Furthermore, EUC participants received four brief monthly check-in calls from study staff to review the resource list and assess current anxiety symptoms, with their providers being alerted in the event of significant anxiety symptoms.
Baseline
STARTED
134
91
Baseline
COMPLETED
134
91
Baseline
NOT COMPLETED
0
0
4 Month
STARTED
134
91
4 Month
COMPLETED
114
83
4 Month
NOT COMPLETED
20
8
8 Month
STARTED
114
83
8 Month
COMPLETED
111
79
8 Month
NOT COMPLETED
3
4
12 Month
STARTED
111
79
12 Month
COMPLETED
106
79
12 Month
NOT COMPLETED
5
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Sex at Birth

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Brief Cognitive Behavioral Therapy for Anxiety (bCBT-A)
n=134 Participants
Participants in the bCBT-A arm were offered 4-9 sessions of measurement-based care, depending on their treatment response by the fourth session. Veterans could receive bCBT-A in person or via VA Video Connect to Home. All participants took part in an initial session where they received psychoeducation on anxiety and the bCBT treatment approach, set goals, and began self-monitoring. Three core skill sessions focused on relaxation, cognitive skills, and exposure techniques followed. All participants received a final wrap-up session to review gains and plan for skill maintenance.
Enhanced Usual Care (EUC)
n=91 Participants
Participants in the EUC group received educational materials on managing anxiety, made available both by mail and through a weblink. They also received a letter encouraging them to discuss treatment options with their VA care providers. Additionally, a note was placed in the participant's electronic medical record to inform their primary care provider (PCP) and most recent Primary Care Mental Health Integration (PCMHI) provider of the presence of anxiety symptoms. Furthermore, EUC participants received four brief monthly check-in calls from study staff to review the resource list and assess current anxiety symptoms, with their providers being alerted in the event of significant anxiety symptoms.
Total
n=225 Participants
Total of all reporting groups
Age, Customized
Age at baseline
53.2 Years
STANDARD_DEVIATION 13.7 • n=129 Participants
53.2 Years
STANDARD_DEVIATION 14.5 • n=22 Participants
53.2 Years
STANDARD_DEVIATION 14.0 • n=151 Participants
Sex/Gender, Customized
Male
78 Participants
n=129 Participants • Sex at Birth
51 Participants
n=22 Participants • Sex at Birth
129 Participants
n=151 Participants • Sex at Birth
Sex/Gender, Customized
Female
56 Participants
n=129 Participants • Sex at Birth
39 Participants
n=22 Participants • Sex at Birth
95 Participants
n=151 Participants • Sex at Birth
Sex/Gender, Customized
Prefer Not To Answer
0 Participants
n=129 Participants • Sex at Birth
1 Participants
n=22 Participants • Sex at Birth
1 Participants
n=151 Participants • Sex at Birth
Race/Ethnicity, Customized
White
45 Participants
n=129 Participants
35 Participants
n=22 Participants
80 Participants
n=151 Participants
Race/Ethnicity, Customized
African American
61 Participants
n=129 Participants
37 Participants
n=22 Participants
98 Participants
n=151 Participants
Race/Ethnicity, Customized
Hispanic / Latino
16 Participants
n=129 Participants
10 Participants
n=22 Participants
26 Participants
n=151 Participants
Race/Ethnicity, Customized
Other
12 Participants
n=129 Participants
9 Participants
n=22 Participants
21 Participants
n=151 Participants
Current Relationship Status
Single / Not in a Relationship
49 Participants
n=129 Participants
23 Participants
n=22 Participants
72 Participants
n=151 Participants
Current Relationship Status
Married / In Civil Union / Living Together
75 Participants
n=129 Participants
62 Participants
n=22 Participants
137 Participants
n=151 Participants
Current Relationship Status
Not Married / Not in Civil Union / Living Apart
10 Participants
n=129 Participants
6 Participants
n=22 Participants
16 Participants
n=151 Participants
Education
<High School / HS / Vocational School
16 Participants
n=129 Participants
13 Participants
n=22 Participants
29 Participants
n=151 Participants
Education
Some College
30 Participants
n=129 Participants
29 Participants
n=22 Participants
59 Participants
n=151 Participants
Education
Associate Degree
23 Participants
n=129 Participants
13 Participants
n=22 Participants
36 Participants
n=151 Participants
Education
Bachelor's Degree
30 Participants
n=129 Participants
20 Participants
n=22 Participants
50 Participants
n=151 Participants
Education
Graduate Degree
35 Participants
n=129 Participants
16 Participants
n=22 Participants
51 Participants
n=151 Participants

PRIMARY outcome

Timeframe: Baseline, 4-, 8-, and 12-month

Population: The number of participants from previous assessments does not become the starting number for the next assessment. If a participant missed an assessment, they are only lost to follow up at that time point, but not future assessments time points. To increase power for the project's secondary outcomes and to reduce unnecessary recruitment, unequal allocation was used where approximately 60% of Veterans will be randomized to bBCT.

The GAD-7 is a seven-item self-report instrument for screening, diagnosis, and severity assessment of anxiety disorders. It is psychometrically strong and valid for use in the primary care setting. A GAD-7 score of 10 or higher will be required for study inclusion. The GAD-7 total score for the seven items ranges from 0 to 21: 0-4 Minimal anxiety; 5-9 Mild anxiety; 10-14 Moderate anxiety; 15-21 Severe anxiety.

Outcome measures

Outcome measures
Measure
Brief Cognitive Behavioral Therapy for Anxiety (bCBT-A)
n=134 Participants
Participants in the bCBT-A arm were offered 4-9 sessions of measurement-based care, depending on their treatment response by the fourth session. Veterans could receive bCBT-A in person or via VA Video Connect to Home. All participants took part in an initial session where they received psychoeducation on anxiety and the bCBT treatment approach, set goals, and began self-monitoring. Three core skill sessions focused on relaxation, cognitive skills, and exposure techniques followed. All participants received a final wrap-up session to review gains and plan for skill maintenance.
Enhanced Usual Care (EUC)
n=91 Participants
Participants in the EUC group received educational materials on managing anxiety, made available both by mail and through a weblink. They also received a letter encouraging them to discuss treatment options with their VA care providers. Additionally, a note was placed in the participant's electronic medical record to inform their primary care provider (PCP) and most recent Primary Care Mental Health Integration (PCMHI) provider of the presence of anxiety symptoms. Furthermore, EUC participants received four brief monthly check-in calls from study staff to review the resource list and assess current anxiety symptoms, with their providers being alerted in the event of significant anxiety symptoms.
General Anxiety Disorder-7 (GAD-7)
Baseline
15.4 score on a scale
Standard Deviation 3.2
14.7 score on a scale
Standard Deviation 3.4
General Anxiety Disorder-7 (GAD-7)
4 Month
11.6 score on a scale
Standard Deviation 5.3
12.0 score on a scale
Standard Deviation 5.1
General Anxiety Disorder-7 (GAD-7)
8 Month
10.9 score on a scale
Standard Deviation 5.2
11.9 score on a scale
Standard Deviation 5.5
General Anxiety Disorder-7 (GAD-7)
12 Month
11.0 score on a scale
Standard Deviation 5.5
10.9 score on a scale
Standard Deviation 6.0

SECONDARY outcome

Timeframe: Baseline, 4-, 8-, and 12-month

Population: The number of participants to start a Period is not equal to the number who completed previous Period.

The OASIS will be a secondary measure of anxiety. Unlike the GAD-7, which will be administered by both research staff and PCMHI providers, the OASIS will only be administered by research staff, thereby avoiding response bias that may occur in the clinical setting. The OASIS is a widely used five-item measure of anxiety for primary care settings assessing anxiety frequency, anxiety severity, avoidance behaviors, social interference, and interference at work, school, or home. Each item of the OASIS instructs respondents to endorse one of five responses that best describes their experiences over the past week. Response items are coded from 0 to 4 and can be summed to obtain a total score ranging from 0 to 20. A higher score indicates a poorer outcome.

Outcome measures

Outcome measures
Measure
Brief Cognitive Behavioral Therapy for Anxiety (bCBT-A)
n=134 Participants
Participants in the bCBT-A arm were offered 4-9 sessions of measurement-based care, depending on their treatment response by the fourth session. Veterans could receive bCBT-A in person or via VA Video Connect to Home. All participants took part in an initial session where they received psychoeducation on anxiety and the bCBT treatment approach, set goals, and began self-monitoring. Three core skill sessions focused on relaxation, cognitive skills, and exposure techniques followed. All participants received a final wrap-up session to review gains and plan for skill maintenance.
Enhanced Usual Care (EUC)
n=91 Participants
Participants in the EUC group received educational materials on managing anxiety, made available both by mail and through a weblink. They also received a letter encouraging them to discuss treatment options with their VA care providers. Additionally, a note was placed in the participant's electronic medical record to inform their primary care provider (PCP) and most recent Primary Care Mental Health Integration (PCMHI) provider of the presence of anxiety symptoms. Furthermore, EUC participants received four brief monthly check-in calls from study staff to review the resource list and assess current anxiety symptoms, with their providers being alerted in the event of significant anxiety symptoms.
Overall Anxiety Severity and Impairment Scale (OASIS)
Baseline
11.6 score on a scale
Standard Deviation 3.7
11.0 score on a scale
Standard Deviation 3.4
Overall Anxiety Severity and Impairment Scale (OASIS)
4 Month
9.6 score on a scale
Standard Deviation 4.6
9.7 score on a scale
Standard Deviation 4.2
Overall Anxiety Severity and Impairment Scale (OASIS)
8 Month
10.2 score on a scale
Standard Deviation 4.4
10.0 score on a scale
Standard Deviation 4.6
Overall Anxiety Severity and Impairment Scale (OASIS)
12 Month
10.0 score on a scale
Standard Deviation 4.4
9.0 score on a scale
Standard Deviation 4.7

SECONDARY outcome

Timeframe: Baseline, 4-, 8-, and 12-month

Population: The number of participants to start a Period is not equal to the number who completed previous Period.

The SF-12-PCS is a condensed, self-reported outcome measure assessing the impart of health on an individual's everyday life. Physical Composite Scores are computed using the score of 12 questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. The investigators will assess quality of life using the 12-item Short Form Health Survey for Veterans (SF12V), an instrument adopted by VHA as a measure of functional status. SF-12V responses can be summarized in component scores for physical (PCS) and mental (MCS) functioning.

Outcome measures

Outcome measures
Measure
Brief Cognitive Behavioral Therapy for Anxiety (bCBT-A)
n=128 Participants
Participants in the bCBT-A arm were offered 4-9 sessions of measurement-based care, depending on their treatment response by the fourth session. Veterans could receive bCBT-A in person or via VA Video Connect to Home. All participants took part in an initial session where they received psychoeducation on anxiety and the bCBT treatment approach, set goals, and began self-monitoring. Three core skill sessions focused on relaxation, cognitive skills, and exposure techniques followed. All participants received a final wrap-up session to review gains and plan for skill maintenance.
Enhanced Usual Care (EUC)
n=89 Participants
Participants in the EUC group received educational materials on managing anxiety, made available both by mail and through a weblink. They also received a letter encouraging them to discuss treatment options with their VA care providers. Additionally, a note was placed in the participant's electronic medical record to inform their primary care provider (PCP) and most recent Primary Care Mental Health Integration (PCMHI) provider of the presence of anxiety symptoms. Furthermore, EUC participants received four brief monthly check-in calls from study staff to review the resource list and assess current anxiety symptoms, with their providers being alerted in the event of significant anxiety symptoms.
Short Form-12 Physical Component Summary (SF-12-PCS)
Baseline
39.9 score on a scale
Standard Deviation 12.3
42.2 score on a scale
Standard Deviation 11.1
Short Form-12 Physical Component Summary (SF-12-PCS)
4 Month
38.5 score on a scale
Standard Deviation 10.3
39.8 score on a scale
Standard Deviation 11.8
Short Form-12 Physical Component Summary (SF-12-PCS)
8 Month
36.6 score on a scale
Standard Deviation 11.0
39.0 score on a scale
Standard Deviation 10.8
Short Form-12 Physical Component Summary (SF-12-PCS)
12 Month
37.8 score on a scale
Standard Deviation 10.8
40.0 score on a scale
Standard Deviation 11.2

SECONDARY outcome

Timeframe: Baseline, 4-, 8-, 12-month

Population: The number of participants to start a Period is not equal to the number who completed previous Period.

The SF12-MCS is a 12-question, patient reported survey evaluating emotional well-being. Mental Health Composite Scores are computed using the score of 12 questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. The investigators assessed quality of life using the 12-item Short Form Health Survey for Veterans (SF12V), an instrument adopted by VHA as a measure of functional status. SF-12V responses can be summarized in component scores for physical (PCS) and mental (MCS) functioning.

Outcome measures

Outcome measures
Measure
Brief Cognitive Behavioral Therapy for Anxiety (bCBT-A)
n=128 Participants
Participants in the bCBT-A arm were offered 4-9 sessions of measurement-based care, depending on their treatment response by the fourth session. Veterans could receive bCBT-A in person or via VA Video Connect to Home. All participants took part in an initial session where they received psychoeducation on anxiety and the bCBT treatment approach, set goals, and began self-monitoring. Three core skill sessions focused on relaxation, cognitive skills, and exposure techniques followed. All participants received a final wrap-up session to review gains and plan for skill maintenance.
Enhanced Usual Care (EUC)
n=89 Participants
Participants in the EUC group received educational materials on managing anxiety, made available both by mail and through a weblink. They also received a letter encouraging them to discuss treatment options with their VA care providers. Additionally, a note was placed in the participant's electronic medical record to inform their primary care provider (PCP) and most recent Primary Care Mental Health Integration (PCMHI) provider of the presence of anxiety symptoms. Furthermore, EUC participants received four brief monthly check-in calls from study staff to review the resource list and assess current anxiety symptoms, with their providers being alerted in the event of significant anxiety symptoms.
Short Form-12 Mental Component Summary (SF12-MCS)
Baseline
35.6 score on a scale
Standard Deviation 9.9
35.6 score on a scale
Standard Deviation 11.3
Short Form-12 Mental Component Summary (SF12-MCS)
4 Month
38.9 score on a scale
Standard Deviation 9.9
37.4 score on a scale
Standard Deviation 12.0
Short Form-12 Mental Component Summary (SF12-MCS)
8 Month
38.4 score on a scale
Standard Deviation 10.9
36.0 score on a scale
Standard Deviation 11.8
Short Form-12 Mental Component Summary (SF12-MCS)
12 Month
37.6 score on a scale
Standard Deviation 11.6
37.4 score on a scale
Standard Deviation 12.0

Adverse Events

Brief Cognitive Behavioral Therapy for Anxiety (bCBT-A)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Enhanced Usual Care (EUC)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Terri L. Fletcher, PhD

Michael E. DeBakey VA Medical Center, Houston, TX

Phone: 713-440-4490

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place